Alicia Marie Quesnel, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Otosclerosis | 13 | 2022 | 110 | 5.820 |
Why?
|
Temporal Bone | 20 | 2024 | 661 | 4.530 |
Why?
|
Cochlear Implants | 12 | 2024 | 339 | 4.170 |
Why?
|
Cochlear Implantation | 11 | 2024 | 310 | 3.650 |
Why?
|
Hearing Loss, Sensorineural | 8 | 2022 | 770 | 1.820 |
Why?
|
Cochlea | 11 | 2024 | 828 | 1.700 |
Why?
|
Stapes Surgery | 5 | 2020 | 60 | 1.580 |
Why?
|
Otologic Surgical Procedures | 3 | 2024 | 145 | 1.560 |
Why?
|
Aerosols | 3 | 2021 | 625 | 1.390 |
Why?
|
Stapes | 3 | 2021 | 88 | 1.130 |
Why?
|
Ear, Inner | 5 | 2022 | 420 | 1.100 |
Why?
|
Hearing Loss | 4 | 2022 | 765 | 1.020 |
Why?
|
Skull Neoplasms | 2 | 2018 | 173 | 0.970 |
Why?
|
Diverticulum | 2 | 2022 | 136 | 0.950 |
Why?
|
Mastoid | 2 | 2020 | 92 | 0.920 |
Why?
|
Hearing | 4 | 2022 | 482 | 0.770 |
Why?
|
Deafness | 2 | 2022 | 458 | 0.750 |
Why?
|
Hearing Loss, Conductive | 3 | 2020 | 158 | 0.740 |
Why?
|
Facial Paralysis | 2 | 2018 | 338 | 0.740 |
Why?
|
Endolymphatic Hydrops | 2 | 2016 | 30 | 0.720 |
Why?
|
Neuroma, Acoustic | 4 | 2023 | 451 | 0.710 |
Why?
|
Cerebellar Ataxia | 1 | 2021 | 145 | 0.690 |
Why?
|
Endoscopy | 3 | 2021 | 1785 | 0.660 |
Why?
|
Ear Diseases | 1 | 2020 | 170 | 0.660 |
Why?
|
Vestibular Diseases | 1 | 2021 | 217 | 0.640 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2018 | 129 | 0.610 |
Why?
|
Electrodes, Implanted | 4 | 2024 | 824 | 0.600 |
Why?
|
Otolaryngology | 2 | 2021 | 645 | 0.580 |
Why?
|
Neurilemmoma | 2 | 2020 | 547 | 0.570 |
Why?
|
Otitis Media | 1 | 2018 | 277 | 0.560 |
Why?
|
Foreign-Body Reaction | 1 | 2017 | 157 | 0.550 |
Why?
|
Hemangiosarcoma | 1 | 2018 | 239 | 0.550 |
Why?
|
Acrocephalosyndactylia | 1 | 2016 | 89 | 0.530 |
Why?
|
Laryngoscopy | 3 | 2011 | 711 | 0.500 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2015 | 95 | 0.500 |
Why?
|
Tympanic Membrane Perforation | 1 | 2014 | 41 | 0.500 |
Why?
|
Hyperacusis | 1 | 2014 | 31 | 0.500 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 547 | 0.500 |
Why?
|
Explosions | 1 | 2014 | 109 | 0.480 |
Why?
|
Medical Futility | 1 | 2015 | 127 | 0.460 |
Why?
|
Round Window, Ear | 2 | 2023 | 47 | 0.450 |
Why?
|
Quadriplegia | 1 | 2015 | 223 | 0.450 |
Why?
|
Tinnitus | 1 | 2014 | 195 | 0.420 |
Why?
|
Diphosphonates | 2 | 2015 | 623 | 0.400 |
Why?
|
Osteoma | 1 | 2011 | 12 | 0.390 |
Why?
|
Blast Injuries | 1 | 2014 | 302 | 0.390 |
Why?
|
Osteogenesis | 4 | 2024 | 1299 | 0.390 |
Why?
|
Petrous Bone | 2 | 2022 | 86 | 0.380 |
Why?
|
Auditory Perception | 1 | 2015 | 569 | 0.380 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.360 |
Why?
|
Cadaver | 4 | 2023 | 1337 | 0.350 |
Why?
|
Laryngostenosis | 1 | 2011 | 161 | 0.330 |
Why?
|
Speech Perception | 3 | 2022 | 489 | 0.330 |
Why?
|
Parotid Neoplasms | 1 | 2009 | 155 | 0.310 |
Why?
|
Voice Quality | 1 | 2009 | 217 | 0.310 |
Why?
|
Fibrosis | 3 | 2024 | 2029 | 0.300 |
Why?
|
Spinal Cord Injuries | 1 | 2015 | 931 | 0.290 |
Why?
|
Skull | 1 | 2011 | 813 | 0.280 |
Why?
|
Scala Vestibuli | 2 | 2023 | 14 | 0.270 |
Why?
|
Tomography, X-Ray Computed | 12 | 2022 | 20129 | 0.270 |
Why?
|
Humans | 54 | 2024 | 744343 | 0.270 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.270 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
Bone Density Conservation Agents | 1 | 2012 | 773 | 0.260 |
Why?
|
Larynx | 1 | 2009 | 494 | 0.250 |
Why?
|
Pandemics | 3 | 2021 | 8388 | 0.240 |
Why?
|
Bone Conduction | 2 | 2016 | 103 | 0.240 |
Why?
|
Audiometry, Pure-Tone | 2 | 2016 | 204 | 0.240 |
Why?
|
Cochlear Duct | 1 | 2023 | 23 | 0.240 |
Why?
|
Scala Tympani | 1 | 2023 | 35 | 0.230 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2569 | 0.230 |
Why?
|
Carrier Proteins | 1 | 2015 | 5021 | 0.210 |
Why?
|
Hearing Tests | 3 | 2022 | 122 | 0.210 |
Why?
|
Hearing Loss, Sudden | 1 | 2022 | 43 | 0.200 |
Why?
|
Bionics | 2 | 2022 | 42 | 0.200 |
Why?
|
Foot Deformities, Congenital | 1 | 2021 | 59 | 0.200 |
Why?
|
Synostosis | 1 | 2021 | 43 | 0.200 |
Why?
|
Radiography | 4 | 2013 | 7023 | 0.200 |
Why?
|
Reflex, Abnormal | 1 | 2021 | 84 | 0.190 |
Why?
|
Reflex, Vestibulo-Ocular | 1 | 2021 | 85 | 0.190 |
Why?
|
Vestibule, Labyrinth | 1 | 2023 | 235 | 0.190 |
Why?
|
Hand Deformities, Congenital | 1 | 2021 | 146 | 0.180 |
Why?
|
Cautery | 1 | 2020 | 72 | 0.180 |
Why?
|
Fluorescein | 1 | 2020 | 171 | 0.180 |
Why?
|
Audiometry | 2 | 2019 | 241 | 0.170 |
Why?
|
Suction | 1 | 2020 | 267 | 0.170 |
Why?
|
Male | 23 | 2022 | 350118 | 0.150 |
Why?
|
Paranasal Sinuses | 1 | 2020 | 250 | 0.150 |
Why?
|
Nasopharynx | 1 | 2020 | 379 | 0.150 |
Why?
|
Imidazoles | 2 | 2015 | 1206 | 0.150 |
Why?
|
Fatal Outcome | 2 | 2019 | 1850 | 0.150 |
Why?
|
Basilar Membrane | 1 | 2017 | 50 | 0.150 |
Why?
|
Craniofacial Abnormalities | 1 | 2019 | 315 | 0.150 |
Why?
|
Operating Rooms | 2 | 2020 | 817 | 0.150 |
Why?
|
Stapes Mobilization | 1 | 2016 | 8 | 0.140 |
Why?
|
Vestibular Aqueduct | 1 | 2017 | 66 | 0.140 |
Why?
|
Adult | 16 | 2022 | 214055 | 0.130 |
Why?
|
Radiosurgery | 2 | 2018 | 1329 | 0.130 |
Why?
|
Community Health Nursing | 1 | 1995 | 24 | 0.130 |
Why?
|
Microscopy | 1 | 2020 | 903 | 0.130 |
Why?
|
Aged | 9 | 2022 | 163280 | 0.120 |
Why?
|
Tympanoplasty | 1 | 2014 | 71 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2023 | 77449 | 0.120 |
Why?
|
Occupational Health | 1 | 2020 | 809 | 0.120 |
Why?
|
Immunity, Mucosal | 1 | 1997 | 490 | 0.110 |
Why?
|
Immunoglobulins | 1 | 1997 | 881 | 0.110 |
Why?
|
France | 1 | 2015 | 517 | 0.110 |
Why?
|
Incidence | 3 | 2016 | 20947 | 0.110 |
Why?
|
Decompression, Surgical | 1 | 2018 | 594 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 822 | 0.110 |
Why?
|
Cervix Uteri | 1 | 1997 | 590 | 0.110 |
Why?
|
Hair Cells, Auditory | 1 | 2015 | 361 | 0.110 |
Why?
|
Etidronic Acid | 1 | 2012 | 64 | 0.110 |
Why?
|
Middle Aged | 11 | 2022 | 213383 | 0.110 |
Why?
|
Comorbidity | 2 | 2020 | 10388 | 0.100 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2879 | 0.100 |
Why?
|
Vagina | 1 | 1997 | 825 | 0.100 |
Why?
|
Autopsy | 1 | 2015 | 1020 | 0.100 |
Why?
|
Nurse Practitioners | 1 | 1995 | 270 | 0.100 |
Why?
|
Neurofibromatosis 2 | 1 | 2015 | 380 | 0.100 |
Why?
|
Female | 17 | 2022 | 380194 | 0.100 |
Why?
|
Auditory Threshold | 1 | 2012 | 364 | 0.100 |
Why?
|
Laryngoplasty | 1 | 2011 | 53 | 0.090 |
Why?
|
Ear, Middle | 1 | 2013 | 334 | 0.090 |
Why?
|
Vascular Malformations | 1 | 2016 | 454 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1855 | 0.090 |
Why?
|
Tracheostomy | 2 | 2011 | 401 | 0.090 |
Why?
|
Hyperostosis, Diffuse Idiopathic Skeletal | 1 | 2009 | 24 | 0.090 |
Why?
|
Dilatation | 1 | 2011 | 291 | 0.090 |
Why?
|
Glottis | 1 | 2011 | 217 | 0.090 |
Why?
|
Syndrome | 1 | 2015 | 3251 | 0.090 |
Why?
|
Algorithms | 1 | 2009 | 13881 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2015 | 2110 | 0.080 |
Why?
|
Recovery of Function | 1 | 2018 | 2925 | 0.080 |
Why?
|
Reoperation | 2 | 2022 | 4201 | 0.080 |
Why?
|
Semicircular Canals | 2 | 2020 | 198 | 0.070 |
Why?
|
Watchful Waiting | 1 | 2011 | 492 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2019 | 57776 | 0.070 |
Why?
|
Adolescent | 8 | 2019 | 85781 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2018 | 35421 | 0.070 |
Why?
|
Microsurgery | 1 | 2011 | 796 | 0.070 |
Why?
|
Treatment Outcome | 4 | 2015 | 63114 | 0.070 |
Why?
|
Delayed Diagnosis | 1 | 2009 | 441 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2023 | 21746 | 0.070 |
Why?
|
Clinical Competence | 1 | 2021 | 4687 | 0.060 |
Why?
|
Treatment Failure | 1 | 2011 | 2618 | 0.060 |
Why?
|
Airway Obstruction | 1 | 2009 | 664 | 0.060 |
Why?
|
Patient Preference | 1 | 2011 | 890 | 0.060 |
Why?
|
Age Factors | 2 | 2011 | 18370 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19905 | 0.060 |
Why?
|
Laser Therapy | 1 | 2011 | 1072 | 0.060 |
Why?
|
Deglutition Disorders | 1 | 2009 | 605 | 0.060 |
Why?
|
Biopsy | 1 | 2015 | 6756 | 0.060 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 975 | 0.060 |
Why?
|
Infant | 4 | 2017 | 35136 | 0.050 |
Why?
|
Endoscopes | 1 | 2024 | 175 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2019 | 4584 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2015 | 3679 | 0.050 |
Why?
|
Length of Stay | 1 | 2015 | 6309 | 0.050 |
Why?
|
Carpal Bones | 1 | 2021 | 77 | 0.050 |
Why?
|
Young Adult | 4 | 2019 | 56430 | 0.050 |
Why?
|
Tarsal Bones | 1 | 2021 | 65 | 0.050 |
Why?
|
Skull Base | 1 | 2024 | 306 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8949 | 0.050 |
Why?
|
Cohort Studies | 2 | 2014 | 40561 | 0.050 |
Why?
|
Disease Progression | 1 | 2016 | 13284 | 0.040 |
Why?
|
Prospective Studies | 2 | 2014 | 53288 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8340 | 0.040 |
Why?
|
Child | 4 | 2017 | 77709 | 0.040 |
Why?
|
Quality of Life | 2 | 2020 | 12804 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2019 | 535 | 0.040 |
Why?
|
Carcinoma | 1 | 2009 | 2375 | 0.040 |
Why?
|
Prognosis | 2 | 2015 | 29063 | 0.040 |
Why?
|
Disposable Equipment | 1 | 1997 | 43 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2009 | 2400 | 0.040 |
Why?
|
Sex Factors | 1 | 2011 | 10397 | 0.040 |
Why?
|
Spiral Ganglion | 1 | 2017 | 169 | 0.030 |
Why?
|
Child, Preschool | 3 | 2017 | 41006 | 0.030 |
Why?
|
Risk Assessment | 2 | 2020 | 23338 | 0.030 |
Why?
|
Vestibular Nerve | 1 | 2015 | 101 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1401 | 0.030 |
Why?
|
Professional Autonomy | 1 | 1995 | 177 | 0.030 |
Why?
|
Guinea Pigs | 1 | 2015 | 1386 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2016 | 15295 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2024 | 2002 | 0.030 |
Why?
|
Observer Variation | 1 | 2017 | 2593 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 29786 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2011 | 25625 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25043 | 0.020 |
Why?
|
Reference Values | 1 | 2017 | 4982 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 3870 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39050 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2530 | 0.020 |
Why?
|
Risk Factors | 1 | 2015 | 72290 | 0.020 |
Why?
|
Hypertrophy | 1 | 2009 | 569 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5655 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4042 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7279 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10638 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15540 | 0.010 |
Why?
|
Animals | 2 | 2022 | 168757 | 0.010 |
Why?
|
United States | 1 | 2020 | 69872 | 0.010 |
Why?
|